Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecobalamin Injection vs Tablet in Diabetic Peripheral Neuropathy
NCT04372316Phase 2Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2017
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mecobalamin in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Inferior Whorl Length at 8 weeks. Status: unknown.
02
Drugs
mecobalamin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT04372316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372316.